COVID-19: China’s Sinopharm says its vaccine is close to 80% effective
A late-stage human trial of a Chinese vaccine in the United Arab Emirates has yielded positive results, the UAE’s national health authorities said Wednesday, citing an 86% efficacy rate for the vaccine..
This figure was announced by the UAE Ministry of Health through the state news agency WAM, which details «interim analysis», carried out Sinopharm – China National Biotechnology Group (CNBG). In the Gulf State of 10 million, the third phase of human trials of an experimental vaccine began in July, and emergency use for healthcare workers was approved in September..
«The registration of this vaccine is a decision in response to Sinopharm’s CNBG application. This announcement is a strong vote of confidence by the UAE health authorities in the safety and efficacy of this vaccine.», – the health ministry said Wednesday. The vaccine itself was developed by the Beijing Institute of Biological Product..
According to the ministry, in the studies, the 3 phases adopted the participation of a group of 31,000 volunteers, belonging to 125 different nationalities, emphasizing that the diverse and large number of expatriates in the UAE, accounting for approximately 90% of the total population of the country, is an advantage when conducting vaccine tests in humans. Volunteers aged 18-60 received two doses of vaccine within 28 days.
However, the statement contains few details. It did not elaborate on trial parameters, such as the number of patients who received a dose of vaccine versus a placebo dose, and did not mention any side effects the patients may have experienced..
Citing an 86% efficiency rate, the ministry stated: «The analysis also shows that the vaccine has 99 percent seroconversion of neutralizing antibodies and 100 percent effectiveness in preventing moderate to severe cases.». Seroconversion is the process by which an antibody is identified in the patient’s blood.
The ministry also added that «analysis shows no serious security problems».
From the statement, unfortunately, it is not quite clear how the 86% efficiency rate was calculated.
Ruler of dubai sheikh Mohammed bin Rashid Al Maktoum (Mohammed bin Rashid al Maktoum) reported in early November that he received a dose of a trial vaccine shortly after the UAE Foreign Minister Sheikh Abdullah bin Zayed Al Nahyan (Abdullah bin Zayed al Nahyan). They both posted photos on Twitter at one time depicting the process of their vaccination..